Portal de Periódicos da CAPES

Drug-Induced Amyopathic Dermatomyositis

2002; Lippincott Williams & Wilkins; Volume: 8; Issue: 1 Linguagem: Inglês

10.1097/00124743-200202000-00011

1536-7355

Luis Felipe Flores-Suárez, Hugo Manuel Paz Morales, Arturo Ángeles, Arnoldo Kraus,

Skin Diseases and Diabetes

Amyopathic dermatomyositis is a rare condition. We describe the clinical and histopathologic findings of a 53-year-old woman who developed cutaneous lesions similar to those described in dermatomyositis after fibrate therapy for hypertriglyceridemia. Our patient fits the proposed criteria for amyopathic dermatomyositis, and after 8.5 years, muscular involvement has not been detected, although the dermatologic lesions are still present despite different treatments reported to treat this condition (steroids, antimalarials, methotrexate, dapsone). However, an initial good response has been observed with thalidomide, a drug used increasingly in the dermatologic field. As far as we know, this case is the first of drug-induced amyopathic dermatomyositis.